rs60917039

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000578416.1(MIR548AL):​n.54G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 154,432 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.015 ( 50 hom., cov: 32)
Exomes 𝑓: 0.0088 ( 0 hom. )

Consequence

MIR548AL
ENST00000578416.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.365

Publications

3 publications found
Variant links:
Genes affected
MIR548AL (HGNC:41736): (microRNA 548al) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0146 (2227/152276) while in subpopulation AFR AF = 0.0486 (2020/41564). AF 95% confidence interval is 0.0468. There are 50 homozygotes in GnomAd4. There are 1016 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 50 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR548ALNR_039710.1 linkn.54G>A non_coding_transcript_exon_variant Exon 1 of 1
MIR548ALunassigned_transcript_1933 n.-11G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR548ALENST00000578416.1 linkn.54G>A non_coding_transcript_exon_variant Exon 1 of 1 6
ENSG00000255440ENST00000524441.2 linkn.105+361G>A intron_variant Intron 1 of 2 2
ENSG00000254631ENST00000531906.5 linkn.258+1385G>A intron_variant Intron 2 of 2 4

Frequencies

GnomAD3 genomes
AF:
0.0145
AC:
2201
AN:
152158
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0481
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00916
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
346
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00881
AC:
19
AN:
2156
Hom.:
0
Cov.:
0
AF XY:
0.0103
AC XY:
11
AN XY:
1072
show subpopulations
African (AFR)
AF:
0.0270
AC:
2
AN:
74
American (AMR)
AF:
0.00
AC:
0
AN:
6
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.00
AC:
0
AN:
92
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.00920
AC:
15
AN:
1630
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
164
Other (OTH)
AF:
0.0108
AC:
2
AN:
186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2227
AN:
152276
Hom.:
50
Cov.:
32
AF XY:
0.0136
AC XY:
1016
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0486
AC:
2020
AN:
41564
American (AMR)
AF:
0.00908
AC:
139
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68014
Other (OTH)
AF:
0.00946
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0103
Hom.:
4
Bravo
AF:
0.0166
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
13
DANN
Benign
0.95
PhyloP100
0.36
Mutation Taster
=97/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60917039; hg19: chr11-74110335; API